EMD-52255

Single-particle
2.0 Å
EMD-52255
3D View Gallery
Deposition: 04/12/2024
Map released: 17/12/2025
Last modified: 01/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52255

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9hli summary report (pdf.gz) Map-9hli FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor

EMD-52255

Single-particle
2.0 Å
EMD-52255
3D View Gallery
Deposition: 04/12/2024
Map released: 17/12/2025
Last modified: 01/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus
Sample: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor
Fitted models: 9hli

Deposition Authors: Moran E, Davies G
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents.
Vriends MBL , Moran E, Calvelo M, Hansen T , Pickles IB , Xin X , Biezeno M, Armstrong ZWB, Ferraz MJ , Li L , Lilley A , Harvey R , Filippov DV , Liao Q , Schroder SP, van der Marel GA , Artola M , Aerts JMFG , Blaza JN , Codee JDC , Rovira C , Overkleeft HS , Davies GJ
(2026) PNAS , 123 , e2504045123 - e2504045123
PUBMED: 41871250
DOI: doi:10.1073/pnas.2504045123
ISSN: 1091-6490
ASTM: PNASA6
Grant Support: